IS6694A - 4-, 5-, 6- og 7-indólafleiður sem eru nytsamlegarvið meðhöndlun á MTK-truflunum - Google Patents

4-, 5-, 6- og 7-indólafleiður sem eru nytsamlegarvið meðhöndlun á MTK-truflunum

Info

Publication number
IS6694A
IS6694A IS6694A IS6694A IS6694A IS 6694 A IS6694 A IS 6694A IS 6694 A IS6694 A IS 6694A IS 6694 A IS6694 A IS 6694A IS 6694 A IS6694 A IS 6694A
Authority
IS
Iceland
Prior art keywords
mtk
disorders
treatment
indole derivatives
derivatives useful
Prior art date
Application number
IS6694A
Other languages
English (en)
Inventor
Bang-Andersen Benny
Kehler Jan
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of IS6694A publication Critical patent/IS6694A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
IS6694A 2000-08-18 2003-01-20 4-, 5-, 6- og 7-indólafleiður sem eru nytsamlegarvið meðhöndlun á MTK-truflunum IS6694A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001229 2000-08-18
PCT/DK2001/000547 WO2002016349A1 (en) 2000-08-18 2001-08-17 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders

Publications (1)

Publication Number Publication Date
IS6694A true IS6694A (is) 2003-01-20

Family

ID=8159658

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6694A IS6694A (is) 2000-08-18 2003-01-20 4-, 5-, 6- og 7-indólafleiður sem eru nytsamlegarvið meðhöndlun á MTK-truflunum

Country Status (29)

Country Link
US (2) US6958338B2 (is)
EP (1) EP1309586B1 (is)
JP (1) JP2004506731A (is)
KR (1) KR20030022363A (is)
CN (1) CN1243750C (is)
AR (1) AR030357A1 (is)
AT (1) ATE321040T1 (is)
AU (2) AU7961101A (is)
BG (1) BG107611A (is)
BR (1) BR0113452A (is)
CA (1) CA2419266A1 (is)
CZ (1) CZ2003461A3 (is)
DE (1) DE60118205T2 (is)
DK (1) DK1309586T3 (is)
EA (1) EA006155B1 (is)
ES (1) ES2257424T3 (is)
HR (1) HRP20030052A2 (is)
HU (1) HUP0302777A2 (is)
IL (1) IL154051A0 (is)
IS (1) IS6694A (is)
MX (1) MXPA03000838A (is)
NO (1) NO20030522D0 (is)
NZ (1) NZ523786A (is)
PL (1) PL363309A1 (is)
PT (1) PT1309586E (is)
SK (1) SK3212003A3 (is)
UA (1) UA74837C2 (is)
WO (1) WO2002016349A1 (is)
ZA (1) ZA200300562B (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2520567A3 (en) * 2006-02-23 2012-12-12 Shionogi & Co., Ltd. Nitrogen-containing heterocycle derivatives substituted with cyclic group
US7645789B2 (en) 2006-04-07 2010-01-12 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
US10022352B2 (en) 2006-04-07 2018-07-17 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
NZ596889A (en) 2006-04-07 2013-06-28 Vertex Pharma Use of amide indole derivatives as modulators of ATP-binding cassette transporters
USRE50453E1 (en) 2006-04-07 2025-06-10 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
US8563573B2 (en) 2007-11-02 2013-10-22 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
TWI404702B (zh) * 2007-08-31 2013-08-11 Lundbeck & Co As H 兒茶酚胺衍生物和其前藥
US8802868B2 (en) 2010-03-25 2014-08-12 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
RU2745977C2 (ru) 2010-04-22 2021-04-05 Вертекс Фармасьютикалз Инкорпорейтед Способ получения циклоалкилкарбоксамидо-индольных соединений
AU2013290444B2 (en) 2012-07-16 2018-04-26 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions of (R)-1-(2,2-diflurorbenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarboxamide and administration thereof
JO3425B1 (ar) 2013-07-15 2019-10-20 Novartis Ag مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b
SG10201913575VA (en) 2014-04-15 2020-02-27 Vertex Pharma Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421641A1 (de) * 1984-06-09 1985-12-12 Merck Patent Gmbh, 6100 Darmstadt Indolderivate
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
AU6215594A (en) * 1993-03-18 1994-10-11 Merck Sharp & Dohme Limited Indole derivatives as dopamine d4 antagonists
JPH09512542A (ja) * 1994-04-28 1997-12-16 メルク シヤープ エンド ドーム リミテツド Ｄ▲下４▼リセプタ拮抗剤としてのベンゾフラン誘導体
DE19500689A1 (de) 1995-01-12 1996-07-18 Merck Patent Gmbh Indolpiperidin-Derivate
GB9520731D0 (en) * 1995-10-10 1995-12-13 Merck Sharp & Dohme Therapeutic agents
GB9604036D0 (en) * 1996-02-26 1996-04-24 Merck Sharp & Dohme Therapeutic agents
WO1999037304A1 (en) * 1998-01-27 1999-07-29 Aventis Pharmaceuticals Products Inc. SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
DZ3223A1 (fr) * 1999-10-19 2001-04-26 Merck & Co Inc Inhibiteurs de tyrosine kinases
US6727264B1 (en) * 2001-07-05 2004-04-27 Synaptic Pharmaceutical Corporation Substituted anilinic piperidines as MCH selective antagonists

Also Published As

Publication number Publication date
EA200300278A1 (ru) 2003-06-26
HRP20030052A2 (en) 2005-02-28
DK1309586T3 (da) 2006-07-10
MXPA03000838A (es) 2003-06-06
BG107611A (bg) 2003-12-31
AU7961101A (en) 2002-03-04
PT1309586E (pt) 2006-06-30
NZ523786A (en) 2005-07-29
CN1243750C (zh) 2006-03-01
NO20030522L (no) 2003-02-03
DE60118205T2 (de) 2006-11-02
KR20030022363A (ko) 2003-03-15
PL363309A1 (en) 2004-11-15
UA74837C2 (en) 2006-02-15
HUP0302777A2 (hu) 2003-12-29
CN1447806A (zh) 2003-10-08
US6958338B2 (en) 2005-10-25
EA006155B1 (ru) 2005-10-27
NO20030522D0 (no) 2003-02-03
US20030166665A1 (en) 2003-09-04
US20060004022A1 (en) 2006-01-05
AU2001279611B2 (en) 2006-08-10
SK3212003A3 (en) 2003-07-01
AR030357A1 (es) 2003-08-20
ATE321040T1 (de) 2006-04-15
US7105543B2 (en) 2006-09-12
JP2004506731A (ja) 2004-03-04
IL154051A0 (en) 2003-07-31
CA2419266A1 (en) 2002-02-28
ES2257424T3 (es) 2006-08-01
ZA200300562B (en) 2004-08-23
BR0113452A (pt) 2003-07-15
WO2002016349A1 (en) 2002-02-28
EP1309586B1 (en) 2006-03-22
DE60118205D1 (de) 2006-05-11
HK1059438A1 (en) 2004-07-02
CZ2003461A3 (cs) 2003-05-14
EP1309586A1 (en) 2003-05-14

Similar Documents

Publication Publication Date Title
NO20032801D0 (no) Tiazolderivater for behandling av PPAR relaterte forstyrrelser
CY2009001I1 (el) Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
IS6694A (is) 4-, 5-, 6- og 7-indólafleiður sem eru nytsamlegarvið meðhöndlun á MTK-truflunum
IS6837A (is) 3-Indólín afleiður sem eru nytsamlegar við meðhöndlun á geðrænum og taugafræðilegum truflunum
NO20031480D0 (no) Nye retinoider for behandling av emfysem
BR0109483A (pt) Pró-drogas de derivados de imidazopiridina
IS6137A (is) Meðhöndlun á hugsýkistruflunum
IS6663A (is) Indólafleiður sem eru nytsamlegar við meðhöndlun á MTK-truflunum
IS6642A (is) Indólafleiður sem eru nytsamlegar við meðhöndlun á MTK-truflunum
PT1294710E (pt) Derivados de indole uteis para o tratamento de disturbios do snc
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
IS6098A (is) Ósantant til meðhöndlunar á skaptruflunum
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
IS6652A (is) Indólafleiður sem eru nytsamlegar við meðhöndlun á MTK-truflunum
IS6643A (is) Indólafleiður sem eru nytsamlegar við meðhöndlun á MTK-truflunum
NO20025760D0 (no) S-metyl-dihydro-ziprasidon for behandling av psykiatriske og okkul¶re forstyrrelser
NO20026028D0 (no) Indolderivater nyttige for behandlingen av CNS-forstyrrelser
SI1309586T1 (sl) Derivati 4-,5-,6- in 7-indola uporabni za zdravljenje motenj cns
DK1157987T3 (da) S-nitrosothioler som midler til behandling af kredsløbsforstyrrelser
TR199902015A3 (tr) Aril-sikloheksilamin türevlerinin CNS bozukluklarina karsi kullanilmasi.
IS6198A (is) Ný bispidín efnasambönd sem eru gagnleg við meðhöndlun á hjartsláttarglöpum
IS6200A (is) Ný bispidín efnasambönd sem eru gagnleg við meðhöndlun á hjartsláttarglöpum
SI1294710T1 (en) Indole derivatives useful for the treatment of cns disorders
NO20011189L (no) Innretning for behandling av suspensjoner